These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 16246413

  • 1. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants.
    Peattie RA, Rieke ER, Hewett EM, Fisher RJ, Shu XZ, Prestwich GD.
    Biomaterials; 2006 Mar; 27(9):1868-75. PubMed ID: 16246413
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants.
    Peattie RA, Nayate AP, Firpo MA, Shelby J, Fisher RJ, Prestwich GD.
    Biomaterials; 2004 Jun; 25(14):2789-98. PubMed ID: 14962557
    [Abstract] [Full Text] [Related]

  • 3. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
    Pike DB, Cai S, Pomraning KR, Firpo MA, Fisher RJ, Shu XZ, Prestwich GD, Peattie RA.
    Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels.
    Riley CM, Fuegy PW, Firpo MA, Shu XZ, Prestwich GD, Peattie RA.
    Biomaterials; 2006 Dec; 27(35):5935-43. PubMed ID: 16950508
    [Abstract] [Full Text] [Related]

  • 5. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
    Cai S, Liu Y, Zheng Shu X, Prestwich GD.
    Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels.
    Elia R, Fuegy PW, VanDelden A, Firpo MA, Prestwich GD, Peattie RA.
    Biomaterials; 2010 Jun; 31(17):4630-8. PubMed ID: 20227760
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
    Ishihara M, Obara K, Ishizuka T, Fujita M, Sato M, Masuoka K, Saito Y, Yura H, Matsui T, Hattori H, Kikuchi M, Kurita A.
    J Biomed Mater Res A; 2003 Mar 01; 64(3):551-9. PubMed ID: 12579570
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis.
    Gao F, Liu Y, He Y, Yang C, Wang Y, Shi X, Wei G.
    Matrix Biol; 2010 Mar 01; 29(2):107-16. PubMed ID: 19913615
    [Abstract] [Full Text] [Related]

  • 11. Sequential delivery of dexamethasone and VEGF to control local tissue response for carbon nanotube fluorescence based micro-capillary implantable sensors.
    Sung J, Barone PW, Kong H, Strano MS.
    Biomaterials; 2009 Feb 01; 30(4):622-31. PubMed ID: 18996588
    [Abstract] [Full Text] [Related]

  • 12. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW, Tegnell E, Toporek SS, Reichert WM.
    Biomaterials; 2005 Jun 01; 26(16):3285-97. PubMed ID: 15603824
    [Abstract] [Full Text] [Related]

  • 13. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
    Yoon JJ, Chung HJ, Park TG.
    J Biomed Mater Res A; 2007 Dec 01; 83(3):597-605. PubMed ID: 17503533
    [Abstract] [Full Text] [Related]

  • 14. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis.
    Patil SD, Papadmitrakopoulos F, Burgess DJ.
    J Control Release; 2007 Jan 22; 117(1):68-79. PubMed ID: 17169457
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
    Lee F, Chung JE, Kurisawa M.
    J Control Release; 2009 Mar 19; 134(3):186-93. PubMed ID: 19121348
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of angiogenic activities of hyaluronan oligosaccharides of defined minimum size.
    Cui X, Xu H, Zhou S, Zhao T, Liu A, Guo X, Tang W, Wang F.
    Life Sci; 2009 Oct 07; 85(15-16):573-7. PubMed ID: 19720068
    [Abstract] [Full Text] [Related]

  • 18. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
    Layman H, Li X, Nagar E, Vial X, Pham SM, Andreopoulos FM.
    J Biomater Sci Polym Ed; 2012 Oct 07; 23(1-4):185-206. PubMed ID: 21192837
    [Abstract] [Full Text] [Related]

  • 19. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
    Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH.
    Biomaterials; 2007 Feb 07; 28(6):1123-31. PubMed ID: 17113636
    [Abstract] [Full Text] [Related]

  • 20. Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels.
    Peattie RA, Pike DB, Yu B, Cai S, Shu XZ, Prestwich GD, Firpo MA, Fisher RJ.
    Drug Deliv; 2008 Aug 07; 15(6):389-97. PubMed ID: 18686083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.